Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Belgium / NCT07703683
Recruiting Observational

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

NCT07703683 · tracked via the Priya Life Science Belgium tracker
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase
Observational
Started
2026-02-19
Last updated
2026-07-14

Condition(s) studied

DiabetesObesity & OverweightCushing SyndromeMetabolic DiseasesEndocrine DiseasesSarcopeniaSarcopenic Obesity

Investigational drug(s) / intervention(s)

GLP-1 Receptor Agonists

GLP-1 Receptor Agonists: Participants receive GLP-1 RA or GLP-1/GIP dual agonists as part of their standard care for overweight or obesity

Study summary

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.

.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Metabolic or endocrine disease Exclusion Criteria: * Known myopathy * Systemic steroid use (\> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome * Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol * History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor

Primary outcome measure(s)

  • Prevalence of sarcopenia / sarcopenic obesity — From February 2026 to december 2056

Trial sites (1)

FacilityCityRegionStatus
Cliniques Universitaires Saint-Luc Woluwe-Saint-Pierre - Sint-Pieters-Woluwe Belgium Recruiting

More Cliniques universitaires Saint-Luc- Université Catholique de Louvain trials in Belgium

Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure Starting soon
BELux Children OutcoME During A(@)Dulthood With GHD Recruiting
New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac Arrest Recruiting
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference Starting soon
Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases Recruiting

Other trials for the same condition

Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center Enrolling by invitation
Studying the Impairment of Stroke and Sarcopenia Patients Using Maximum Voluntary Contractions of the Leg Joints. Active, not recruiting
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device Recruiting
Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With Obesity Recruiting
Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07703683 on ClinicalTrials.gov ↗ ← All trials in Belgium